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1. Introduction
  Schistosomiasis, one of the neglected tropical diseases[1], is 
still a major public health concern affecting over 207 million 
people in 76 countries, with a further 779 million people 
at risk of infection with one of the causative parasites[2]. 
Schistosomiasis japonica, caused by infection with 
Schistosoma japonicum (S. japonicum), was considered as 
one of the most serious parasitic diseases that were endemic 
in China[3-5]. Large-scale schistosomiasis control programs 
since the 1950s have dramatically reduced the number of 
the areas endemic for the parasite as well as the burden of 
disease among humans[6-12], and the control achievements 
were further consolidated by the World Bank Loan Project 
(WBLP) for Schistosomiasis Control initiated since 1992 in 
China[13-16]. Nevertheless, following the termination of the 
WBLP for Schistosomiasis Control in 2001, and the effects 
Objective: To assess the diagnostic efficacy of the currently most widely used indirect 
hemagglutination assay (IHA) and enzyme-linked immunosorbent assay (ELISA) for detection of 
Schistosoma japonicum human infections. Methods: A comprehensive search was undertaken 
from China National Knowledge Infrastructure, Wanfang Database, VIP Database, PubMed, 
Cochrane Library, Science Citation Index Expanded, Proquest, and the inclusion and exclusion 
criteria were strictly settled. The funnel plot was used to assess the publication bias, Cochran’s 
Q test was employed to measure the homogeneity between studies, a summary receiver operating 
characteristic (SROC) curve was used to compare the diagnostic accuracy between the IHA and 
ELISA qualitatively by means of the Weighted Least Square method, the Ordinary Least Square 
method and the Robust regression method, and the diagnostic odds ratio (DOR) was drawn to 
compare the accuracy quantitatively. Results: Out of 785 publications, 19 papers were eventually 
selected for analysis. Literature quality assessment indicated that minor publication bias existed 
in studies pertaining IHA test, but no bias was found in literatures regarding ELISA test. The 
heterogeneity test showed a heterogeneity between studies was present (氈2=466.07 and 34.67, 
both P values<0.0001). The areas under the SROC curves of IHA were all higher than that of 
ELISA test using the three methods (Weighted Least Square method: 0.766 vs. 0.695, Ordinary 
Least Square method: 0.826 vs. 0.741, Robust regression: 0.815 vs. 0.715). The TPR* values for 
IHA and ELISA were 0.710, 0.759, 0.749, and 0.650, 0.686 and 0.666, respectively, and OR values 
were 5.997, 9.937, 8.893, and 3.432, 4.784 and 3.959, respectively. The DOR of IHA was 9.41 (95% 
CI: 4.88-18.18), and 4.78 (95% CI: 3.21-7.13) for ELISA. Conclusions: All above results revealed 
that the diagnostic performance of IHA is better than that of ELISA. However, taking into account 
their unsatisfactory diagnostic value in areas with low infection intensity, a search for a better 
diagnostic test that can be applied in field situations in China should be given high priority.
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of major floods along the Yangtze River valley and several 
other factors[17-26], schistosomiasis japonica was resurged 
in China[27-29], and currently the core endemic regions are 
mainly located in the lake regions of five provinces along the 
middle and lower reaches of the Yangtze River, and in some 
mountainous areas in the provinces of Sichuan and Yunnan, 
and over 0.7 million people living in China are thought to 
have the disease[30-33]. 
  Diagnosis is central to the control of schistosomiasis[34,35]. 
It can be divided into direct parasitological techniques 
(detection of parasite eggs) like the Kato-Katz technique[36] 
and the miracidium hatching method[37], and indirect 
approaches (detection of antibody or circulating antigen in 
serum) including intradermal test, indirect hemagglutination 
assay (IHA), enzyme-linked immunosorbent assay 
(ELISA), circumoval precipitin test[38], dipstick dye 
immunoassay[39,40], etc.  After the long-term implementation 
of national schistosomiasis control programs and large-scale 
praziquantel-based chemotherapy, both the prevalence 
and the intensity of infection of S. japonicum have declined 
dramatically, with the remaining majority of endemic 
foci in China characterized by a low intensity of infection 
independent of prevalence[41,42]. The problem of insensitivity 
of the parasitological techniques surfaced in China in terms 
of the low diagnostic accuracies in areas with low infection 
intensities. In addition, microscopy is time-consuming and 
labor-intensive[35]. 
  Immunodiagnostic techniques, having high sensitivities, are 
easy to perform and are an excellent epidemiological tool for 
screening target populations for chemotherapy in endemic 
foci[34]. These assays are also useful for the surveillance 
of chemotherapy efficacy and for periodic control of 
transmission of the infection after it has been eliminated in 
an area[35]. Currently, ELISA and IHA are most widely used 
in China for immunodiagnosis of schistosomiasis japonica in 
the schistosome-endemic areas[35]. Many studies have been 
carried out to assess the diagnostic accuracies of different 
assays both in laboratory and in field settings in China. Due 
to the variation of experimental conditions, the values of the 
immunodiagnostic tests were vastly different, which would 
lead to the inaccurate estimates of the prevalence and the 
targets for chemotherapy. In addition, inaccurate evaluations 
impact the government decision-makers to formulate the 
disease control strategy[35,38]. Considering the fact that 
both ELISA and IHA tests were extensively used in China, 
a comprehensive and more accurate assessment of their 
diagnostic efficacies is of great importance for screening, 
epidemiological survey and control of schistosomiasis. We, 
therefore, conducted an integrated meta-analysis to assess 
the immunodiagnostic efficacies of the ELISA and IHA tests 
for detection of S. japonicum human infections in the field.
2. Materials and methods
 2.1. Search strategy and data source
  Electronic databases including China National Knowledge 
Infrastructure, Wanfang Database, VIP Database, PubMed, 
Cochrane Library, Science Citation Index Expanded, 
Proquest, and conference abstracts/hand searching were 
jointly employed for a comprehensive ascertainment to 
search data concerning the diagnostic efficacy of ELISA or 
IHA for schistosomiasis japonica in China. No restriction 
was applied to year of publication, because we did not want 
to miss any publications. All titles and abstracts were read 
carefully, and the full texts of the screened publications 
were reviewed.
2.2.  Study selection
  Both of the inclusion criteria and exclusion criteria for 
searching the publications were settled in the first stage 
of the meta-analysis. A text was included if it met all of 
the following criteria: (1) Sensitivity and specificity were 
reported or could be calculated; (2) IHA or ELISA test 
was used for immunodiagnosis on human infections; (3) 
The diagnostic value was identified by any gold standard 
methods of parasitological examinations such as Kato-
Katz or the miracidium hatching test; (4) A schistosome-
endemic region with intensity of infection was enrolled; (5) 
The full text was available for review. While the literatures 
failed to meet the criteria mentioned above or were unclear 
to inadequately present a certain term, then they were 
excluded.
2.3. Assessment of literature quality
  The funnel plot was drawn to evaluate the literature quality 
using software Review Manager 4.2, and the funnel plot 
asymmetry indicated the emergence of publication bias.
2.4. Meta analysis
  All data pertaining to IHA, ELISA, the gold standard used 
and the indicators of diagnostic accuracy including true 
positives (TP), false positives (FP), false negatives (FN) 
and true negatives (TN), sensitivity and specificity were 
initially extracted into a spreadsheet. Before merging the 
effect size, the heterogeneity test should be carried out 
to identify the homogeneity of the studies. We employed 
Cochran’s Q test to measure the homogeneity between 
studies[43]. Following the heterogeneity test, the random 
effects model were used to estimate overall studies in order 
to take into account heterogeneity in the sources, and the 
sensitivity, specificity, likelihood ratio (LR) were merged. 
A summary receiver operating characteristic (SROC) curve 
was fit to compare the diagnostic accuracy between the IHA 
and ELISA qualitatively. Following a logit transformation, 
D=ln[(TP×TN)/(FN×FP)], S=ln[(TP×FP)/(TN×FN)]. Where 
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D represents accuracy, namely a lnOR value of diagnostic 
tests; and S represents range of positive standard. Each 
indicator was added up 0.5 to avoid the emergence of 0. 
An SROC linear regression model was established between 
D and S, and the model is D=A+BS, namely TPR={1+e-A/
(1-B)[(1-FPR)/FPR](1+B)(1-B)}-1, while A and B represent the 
regression intercept and coefficient, respectively, which was 
calculated by the Weighted Least Square method, Ordinary 
Least Square method and Robust regression in this study. 
The sensitivity and specificity for the single test threshold 
identified for each study were used to plot an SROC curve, 
while the y axis represents TPR (sensitivity), and x axis 
for FPR (1-specificity). The area under curve (AUC) was 
calculated, and bigger AUC indicates better accuracy of the 
diagnostic tests. The odds ratios (ORs) of the two diagnostic 
tests were merged weightedly to compare the accuracy 
quantitatively, and the forest plot was drawn.
  All statistical analyses and drawings were done in software 
Review Manager 4.2 and Meta-disc recommended by the 
Cochrane Collaboration.
3. Results
3.1. Literature searched
  A total of 785 potentially related documents were identified. 
The flow chart in Figure 1 shows the steps of the process 
for the study selection, including the number of papers 
identified and number for exclusion of articles according 
to the criteria. Finally, a total of 19 papers were enrolled in 
the present study, among which 10 reported IHA, 5 reported 
ELISA and another 4 articles reported both. The diagnostic 
accuracy of both ELISA and IHA for schistosomiasis japonica 
presented a wide range of values. Among these studies, 
the sensitivity of IHA ranged from 37.6% (32.1%-43.3%) to 
95.1% (83.5%-99.4%) and specificity from 35.7% (33.2%-
38.2%) to 93.8% (91.6%-95.6%), while the sensitivity of 
ELISA spanned from 57.1% (42.2%-71.2%) to 97.3% (93.9%-
99.1%) and specificity from 20.4% (16.5%-24.7%) to 84.3% 
(80.5%-87.5%). Details concerning the enrolled literatures 
are shown in Table 1[44-62]. 
785 potential related papers were 
scanned
711 were excluded for lack of 
relevance or full text
74 papers with full text were 
retrieved
55 were excluded for not meeting 
the inclusion criteria after the 
whole paper review
19 papers were enrolled in the 
present fstudy
Figure 1.  The flowchart of the process of study selection.
3.2. Literature quality assessment
  According to the funnel graphs (Figure 2a and 2b), the 
plot pertaining to the diagnostic value of ELISA is almost 
symmetrical, with dense scattering dots, which suggests 
that there is no publication bias found. However, minor 
publication bias still exists in studies regarding the 
diagnostic efficacies of IHA according to the dots in the 
funnel graph.
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Figure 2.  The funnel graphs for analysis of publication bias in studies 
pertaining to the diagnostic values of IHA (2a) and ELISA (2b).
3.3. Meta analysis  
  The heterogeneity test indicated the existence of 
heterogeneity between studies (For IHA, 氈
2=466.07, 
P<0.0001; for ELISA, 氈
2=34.67, P<0.0001), then the weighted 
merging sensitivity, specificity, LR and the corresponding 
95% CI were calculated using random effects models and the 
results were presented in Table 2. 
  The SROC curves present a global summary of the 
performances of diagnostic tests. The SROC linear regression 
model fitting about IHA and ELISA were presented in Table 
3, and the parameters in the SROC linear regression model 
calculated by the three methods (the Weighted Least 
Square method, Ordinary Least Square method and Robust 
regression) were shown in Table 4. Our findings showed 
that all TPR* of IHA were higher than that of ELISA, which 
suggests that the diagnostic accuracy of IHA for cases was 
higher than that of ELISA. In addition, all OR values for IHA 
test using the three statistical methods were higher than that 
of ELISA. The linear regression models of IHA and ELISA 
which were fit using the three methods were presented as 
follows, and then the SROC curve was drawn according to the 
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Table 1
Sensitivity, specificity, LR and corresponding 95% CI of IHA and ELISA in the enrolled studies.
Author and year of
publication
Sensitivity
 (%, 95% CI)
Specificity 
(%, 95% CI)
LR+ (95% CI) LR- (95% CI) Selection of golden standard
IHA Li et al. 2003 82.8(71.3-91.1) 70.0(66.2-73.5) 2.756
(2.339-3.247)
0.246
(0.143-0.422)
Kato-Katz (3 slides for one fecal sample)
Jin et al. 2005 37.6(32.1-43.3) 73.7(71.4-75.9) 1.429
(1.209-1.689)
0.847
(0.772-0.928)
Kato-Katz (3 slides for one fecal sample)
Bao et al. 2006 40.7(32.5-49.3) 86.2(84.6-87.8) 2.959
(2.349-3.729)
0.687(
0.599-0.790)
Miracidium hatching test (3 slides for 3 fecal 
samples)
Liu et al. 2010 77.3(67.1-85.5) 58.1(54.0-62.1) 1.844
(1.591-2.137)
0.391
(0.265-0.578)
Kato-Katz (6 slides for 2 fecal samples)
Xu et al. 2007 * 85.6(78.9-90.9) 35.7(33.2-38.2) 1.331
(1.232-1.437)
0.403
(0.270-0.603)
Kato-Katz or miracidium hatching test (3 slides 
for one fecal sample)
Xu et al. 2007 ** 76.0(68.3-82.7) 63.6(61.1-66.1) 2.090
(1.864-2.343)
0.377
(0.282-0.504)
Kato-Katz or miracidium hatching test (3 slides 
for one fecal sample)
Lin et al. 2008 69.6(55.9-81.2) 88.4(85.5-90.9) 5.998
(4.515-7.966)
0.343
(0.231-0.511)
Kato-Katz (12 slides for 2 fecal samples)
Zhao et al. 2007 95.1(83.5-99.4) 82.4(78.6-85.7) 5.390
(4.372-6.646)
0.059
(0.015-0.229)
Miracidium hatching test (3 slides for 3 fecal 
sample)
Yuan et al. 2008 65.4(56.5-73.5) 81.5(79.1-83.6) 3.526
(2.969-4.188)
0.425
(0.335-0.539)
Miracidium hatching test (3 slides for one fecal 
sample)
Yu et al. 2007 80.3(74.1-85.6) 48.4(37.7-59.1) 1.555
(1.260-1.919)
0.407
(0.286-0.579)
Kato-Katz (2 slides for one fecal samples)
Zhou et al. 2007# 85.9(80.8-90.0) 61.2(58.7-63.6) 2.213
(2.042-2.398)
0.231
(0.168-0.316)
Kato-Katz (3 slides for one fecal sample)
Guan et al. 1999 71.4(65.8-76.6) 44.4(39.1-49.7) 1.284
(1.140-1.446)
0.644
(0.518-0.802)
Miracidium hatching test (1 slide for 1 fecal 
sample) or Kato-Katz(2 slides for one fecal 
sample)
Li et al. 2002 80.0(51.9-95.7) 93.8(91.6-95.6) 12.995
(8.695-19.421)
0.213
(0.077-0.587)
Kato-Katz (2 slides for one fecal samples)
Wu et al. 2000 93.7(91.0-95.7) 89.0(88.1-90.0) 8.549
(7.815- 9.352)
0.071
(0.050-0.102)
Kato-Katz (3 slides for one fecal sample)
Peng et al. 1982 91.3(87.7-94.2) 66.3(64.5-68.0) 2.709
(2.549- 2.880)
0.131
(0.092-0.186)
Miracidium hatching test (3 slides for 3 fecal 
sample)
ELISA Chen et al. 2007 65.5(45.7-82.1) 57.5(51.9-62.9) 1.540
(1.149-2.064)
0.600
(0.360-1.000)
Kato-Katz (4 slides for one fecal sample)
He et al. 2007 95.0(89.4-98.1) 20.4(16.5-24.7) 1.193
(1.118-1.273)
0.246
(0.110-0.549)
Kato-Katz (3 slides for one fecal sample)
Bao et al. 2006 57.1(42.2-71.2) 82.4(79.8-84.8) 3.248
(2.453-4.301)
0.520
(0.376-0.720)
Miracidium hatching test (3 slides for 3 fecal 
samples)
Wang et al. 2005 97.3(93.9-99.1) 24.5(19.9-29.7) 1.289
(1.205-1.379)
0.109
(0.045-0.265)
Kato-Katz (3 slides for 1 fecal sample) or 
miracidium hatching test (1 slide for 1 fecal 
sample)
Xu et al. 2007 65.8(57.5-73.4) 51.7(49.0-54.3) 1.360
(1.196-1.547)
0.663
(0.526-0.835)
Kato-Katz or miracidium hatching test (3 slides 
for one fecal sample)
Lin et al. 2008△ 79.3(69.3-87.3) 53.5(49.2-57.6) 1.704
(1.483-1.958)
0.387
(0.255-0.588)
Kato-Katz or miracidium hatching test (3 slides 
for one fecal sample)
Lin et al. 2008 △△ 87.4(81.8-91.7) 38.9(35.6-42.3) 1.430
(1.325-1.544)
0.325
(0.221-0.476)
Kato-Katz (12 slides for 2 fecal samples)
Zhou et al. 2007# 90.1(85.6-93.5) 38.4(36.0-40.8) 1.462
(1.380-1.548)
0.258
(0.176-0.380)
Miracidium hatching test (3 slides for 3 fecal 
sample)
Yang et al.2007 75.0(34.9-96.8) 39.0(29.4-49.3) 1.230
(0.800-1.889)
0.641
(0.188-2.182)
Miracidium hatching test (3 slides for one fecal 
sample)
Song et al. 2003 83.3(58.6-96.4) 84.3(80.5-87.5) 5.298
(3.932-7.138)
0.198
(0.070-0.556)
Kato-Katz (2 slides for one fecal samples)
LR+: Positive likelihood ratio; LR-: Negative likelihood ratio.
There were two IHA assays in the study conducted by Xu et al. * indicated the result of IHA-A, and ** indicated the result of IHA-B. 
The study conducted by Lin et al was carried out in 2005 and 2006. △ indicated the result of 2005, and △△ indicated the result of 2006. 
# The data were the merged results of two study sites in the study. 
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Table 2
The merging sensitivity, specificity, positive and negative LR of the two diagnostic tests (%, 95% CI).
Diagnostic test Sensitivity Specificity LR+ LR-
IHA 75.6 (73.9-77.3) 73.0 (72.4-73.7) 2.877 (2.106-3.931) 0.306 (0.196-0.480)
ELISA 84.9 (82.6-86.9 ) 50.4 (49.2-51.6) 1.666 (1.443-1.923) 0.367 (0.263-0.511)
Table 3
Characteristics of the SROC regression model fitting about IHA and ELISA.
Author and year of publication TP FP FN TN TPR FPR Weight D S
IHA Li et al. 2003   53 186   11    433 0.828 0.300   8.513 2.417   0.727
Jin et al. 2005 115 401 191 1 124 0.376 0.263 57.754 0.523 -1.538
Bao et al. 2006   57 246   83 1 542 0.407 0.138 29.150 1.460 -2.211
Liu et al. 2010   68 251   20    348 0.773 0.419 13.974 1.551   0.897
Xu et al. 2007 * 125 909   21    504 0.856 0.643 17.035 1.194   2.374
Xu et al. 2007 ** 111 514   35    899 0.760 0.364 24.607 1.713   0.595
Lin et al. 2008   39   67   17    510 0.696 0.116   9.867 2.860 -1.199
Zhao et al. 2007   39   81     2    378 0.951 0.176   1.850 4.511   1.430
Yuan et al. 2008   85 224   45    984 0.654 0.185 25.337 2.116 -0.844
Yu et al. 2001 159   47   39      44 0.803 0.516 13.169 1.339   1.471
Zhou et al. 2007# 207 609   34    960 0.859 0.388 27.081 2.261   1.351
Guan et al. 1999 200 197   80    157 0.714 0.556 34.548 0.689   1.143
Li et al. 2002   12   37     3    564 0.800 0.062   2.245 4.110 -1.338
Wu et al. 2000 413 458   28 3 723 0.937 0.110 24.638 4.787   0.596
Peng et al. 1982 295 978   28 1 923 0.913 0.337 24.602 3.031   1.679
ELISA Chen et al. 2007   19 137   10    185 0.655 0.425   6.048 0.942   0.341
He et al. 2007 114 309     6      79 0.950 0.796   5.226 1.581   4.308
Bao et al. 2006   28 158   21    740 0.571 0.176 10.987 1.832 -1.256
Wang et al. 2005 182 237     5      77 0.973 0.755   4.490 2.470   4.719
Xu et al. 2007   96 683   50    730 0.658 0.483 30.075 0.719   0.586
Lin et al. 2008△   69 263   18    302 0.793 0.465 12.960 1.482   1.205
Lin et al. 2008△△ 166 510   24    325 0.874 0.611 18.965 1.483   2.385
Zhou et al. 2007# 218 967   24    602 0.901 0.616 20.429 1.733   2.680
Yang et al. 2007     6   61     2      39 0.750 0.610   1.411 0.651   1.546
Song et al. 2003   15   70     3    375 0.833 0.157   2.398 3.288 -0.069
TPR: True positive rate; FPR: False positive rate; D=ln[(TP×TN)/(FN×FP)], S=ln[(TP×FP)/(TN×FN)].
There were two IHA assays in the study conducted by Xu et al. * indicated the result of IHA-A, and ** indicated the result of IHA-B. 
The study conducted by Lin et al was carried out in 2005 and 2006. △indicated the result of 2005, and △△ indicated the result of 2006. 
# The data were the merged results of two study sites in the study. 
Table 4
The regression parameters and accuracy of IHA and ELISA in the included studies.
Statistical method A SE(A) 95%CI B SE(B) 95%CI TPR* SE(TPR*) OR
IHA Weighted least square method 1.791 0.322 1.101-2.482 0.235 0.226 - 0.249 - 0.718 0.710 0.033 5.997
Least square method 2.296 0.367 1.508-3.084 0.023 0.264 - 0.543 - 0.590 0.759 0.034 9.937
Robust regression 2.185 - - 0.052 - - 0.749 - 8.893
ELISA Weighted least square method 1.233 0.260 0.644-1.823 0.114 0.124 - 0. 166-0.393 0.650 0.030 3.432
Least square method 1.565 0.364 0.743-2.388 0.032 0.149 - 0.305-0.369 0.686 0.039 4.784
Robust regression 1.376 - - 0.080 - - 0.666 - 3.959
A: regression intercept, B: coefficient, SE: standard error, TPR*: diagnostic accuracy; OR: odds ratio.
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models.
IHA:
TPRWLS={1+e
-2.341[(1-FPR)/FPR]1.614}-1；
TPROLS={1+e
-2.350[(1-FPR)/FPR]1.047}-1；
TPRRobust ={1+e
-2.305[(1-FPR)/FPR]1.110}-1.
ELISA:
TPRWLS={1+e
-1.392[(1-FPR)/FPR]1.257}-1;
TPROLS={1+e
-1.617[(1-FPR)/FPR]1.066}-1; 
TPRRobust={1+e
-1.496[(1-FPR)/FPR]1.174}-1.
  The SROC curves of the diagnostic performances of IHA 
and ELISA were presented in Figures 3a and 3b. The areas 
under the SROC curves of IHA were all higher than that of 
ELISA test using the three methods (Weighted Least Square 
method: 0.766 vs. 0.695, Ordinary Least Square method: 
0.826 vs. 0.741, Robust regression: 0.815 vs. 0.715). It is 
indicated that the diagnostic efficacy of IHA is better than 
that of ELISA, which is similar to the above results revealed 
by TPR* and OR values.
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Figure 3.  The SROC curves of diagnostic efficacies of IHA (3a) and 
ELISA (3b) in the enrolled studies.
  In quantitative comparison, the ORs of IHA and ELISA 
were merged weightedly, the diagnostic odds ratio (DOR) of 
IHA was 9.41 (95% CI: 4.88-18.18), and 4.78 (95% CI: 3.21-
7.13) for ELISA. It is indicated that IHA outperforms ELISA. 
Figures 4a and 4b show the forest plots of DOR for IHA and 
ELISA.
4. Discussion 
  Although great achievements were gained in the control 
of schistosomiasis japonica in China through more than 
50-year efforts, the disease remains a major public-health 
problem in China currently[3-5]. The prevention and control 
of the disease need rapid and reliable diagnostic techniques 
to identify target populations accurately for treatment[34]. 
In this case, diagnosis, as central to schistosomiasis, at 
the levels of both individual and community is essential 
for the control program[35]. Diagnosis of schistosomiasis is 
usually performed by parasitological (microscopic detection 
of eggs), and/or immunological methods (antibody and 
antigen detection). The demonstration of parasite eggs 
in feces directly indicated the presence of the causative 
agent worms, but the disadvantages of this approach 
include a high fluctuation in eggs counts, easily missed low 
infections, a relatively time-consuming methodology and 
low compliance[34,35]. The immunodiagnostic technology, 
owing to its rapid, affordable and easily acceptable (high 
compliance) advantages over parasitological techniques, 
had been, in reality, integrated into the schistosomiasis 
control program in P.R. China as a way to improve the 
diagnostic record in identifying the target populations for 
treatment since early 1980s when the safe and effective 
drug praziquantel was introduced. Many immunodiagnostic 
assays have been developed and applied in China[38-
40,63-65], among them, ELISA and IHA are mostly widely 
used for schistosomiasis diagnosis in field situations of 
China. However, the values of performance index of the 
immunodiagnostic tests varied greatly. It is, therefore, of 
great importance and essential to evaluate their diagnostic 
efficacies in a comprehensive and more accurate way. 
  Results of the current study showed that a large variety 
of the diagnostic efficacy of IHA and ELISA was estimated, 
the sensitivity of IHA ranged from 37.6% to 95.1%, and 
specificity from 35.7% to 93.8%, while the sensitivity of 
ELISA spanned from 57.1% to 97.3% and specificity from 
20.4% to 84.3%. There are many factors that can contribute 
to such a large variation. Apart from the selection of the gold 
standard, some other potential causes for the inconsistence 
of the diagnostic value are listed as follows: (1) The pilot 
areas included in the studies have different environmental 
ecosystems. In terms of geographic characteristics, the 
schistosome-endemic areas in China can be divided into 
3 major types, namely lake and marshland regions, plain 
regions with waterway networks and hilly and mountainous 
regions[30,66]. The diagnostic values of an immunodiagnostic 
reagent may be dissimilar in different types of endemic 
areas[34]; (2) Size of the detection samples; (3) The sensitivity 
and specificity vary with the prevalence and intensity of 
schistosome infection[44,48,49,56]; (4) Different diagnostic 
agents. For example, many antigens can be used to 
establish an ELISA technique. In addition, the assays are 
not supplied by the same manufacturer[48]; (5) Subjective 
factors of the operators[67]. In order to make a comprehensive 
and accuracy evaluation of the diagnostic value of an 
immunodiagnostic assay, all these potential factor that may 
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impact the diagnostic outcomes were taken into account. 
During the review and selection of the papers, the inclusion 
and exclusion criteria were strictly settled. 
  The funnel plots we drew indicated minor publication bias 
exist in the enrolled studies pertaining the diagnostic value 
of IHA. Publication bias is a widespread and particularly 
thorny issue in meta-analysis, which may seriously distort 
attempts to estimate the effect under investigation. There 
are numerous reasons responsible for the existence of the 
bias, including language bias, availability bias, cost bias, 
familiarity bias, outcome bias, and so on[68,69]. In the present 
study, the literatures included have been published in 
national or international journals, but those without publish 
were not collected. The publication bias, therefore, may 
emerge. In addition, due to the limitation of access to the 
literature resources, those paper with easy access to the full 
text and published in English and Chinese were selected, 
which may also lead to the existence of selection bias and 
language bias. Although those bias mentioned above may 
exist, the current study makes use of the limited citations 
to draw a conclusion that IHA is superior in diagnosis of 
schistosomiasis to ELISA, which has been identified by 
previous field trials[46,48,52].  
  Our meta-analysis identified that both of the two 
immunodiagnostic assays are suitable for the detection of 
S. japonicum infections in schistosomiasis control program 
which are revealed by the TPR* values, and IHA shows a 
better diagnostic efficacy in comparison with that that of 
ELISA, suggested by the results of TPR*, OR values as well 
as the AUC of the SROC curve. However, the result revealed 
by the statistical methods is a comprehensive analysis of 
both sensitivity and specificity. Actually, from the result of 
the included studies, we can find the sensitivity of ELISA is 
higher than that of IHA, but the specificity of ELISA is lower. 
Considering sensitivity is given priority in low endemic 
areas, it seems that ELISA test is more suitable for screening 
the target for chemotherapy as a primary approach to cover 
more cases. In addition, these assays proved to have an 
unsatisfactory sensitivity and specificity, especially in 
patients with light infections. Currently in China, in most 
Figure 4.  The forest plots of DOR for IHA (4a) and ELISA (4b) tests. 
Review:           IHA
Comparison:   01 IHA
Outcome:        01 IHA
Study
or sub-category
Treatment
     n /N
Control
   n /N
OR(random)
  95% CI
Weight
   %
OR (random)
   95% CI
Bao et al. 2006
Guan et al. 1999
Jin et al. 2005
Li et al. 2002
Li et al.2003
Lin et al. 2008
Liu et al. 2010
Peng et al. 1982
Wu et al. 2000
Xu et al.2007*
Xu et al. 2007**
Yu et al. 2007
Yuan et al. 2008
Zhao et al. 2007
Zhou et al. 2007#
57/140
200/280
115/305
  12/15
  53/64
  39/56
  68/88
295/323
413/441
125/146
111/146
159/199
  85/130
  39/41
207/241
  246/1 788
197/354
   401/1 525
  37/601
186/619
  67/577
251/599
  978/2 901
458/4 181
909/1 413
514/1 413
    47/91
  224/1 208
81/459
609/1 569
Total (95% CI)                                    2 615                                19 298
Total events: 1 978 (Treatment), 5 205 (Control)
Test for heterogentity: x2=466.07, df=14 (P<0.00001)
Test for overall effect: Z=6.68 (P<0.0001)
6.94
6.96
7.01
5.54
6.60
6.67
6.79
6.91
6.91
6.84
6.91
6.77
6.92
5.29
6.93
    4.30 (2.99, 6.19)
    1.99 (1.43, 2.78)
    1.69 (1.30, 2.18)
  60.97 (16.48, 225.56)
  11.22 (5.73, 21.96)
  17.46 (9.36, 32.59)
    4.71 (2.79, 7.96)
  20.72 (13.95, 30.75)
119.90 (80.79, 177.95)
    3.30 (2.05, 5.31)
    5.55 (3.74, 8.23)
    3.82 (2.22, 6.55)
    8.30 (5.62, 12.25)
  91.00 (21.54, 384.51)
    9.60 (6.59, 13.99)
100.00               9.41 (4.88, 18.18)
0.001 0.01     0.1     1        10     100   1 000
Favours treatment   Favours control
a
Review:          ELISA
Comparison:   01 ELISA
Outcome:        01 ELISA
Study
or sub-category
Control
   n /N
OR(random)
  95% CI 
Weight
   %
OR (random)
   95% CI
Treatment
     n /N
Bao et al. 2006
Chen et al. 2007
He et al. 2007
Lin et al. 2008*
Lin et al. 2008**
Song et al. 2003
Wang et al. 2005
Xu et al. 2007
Yang et al. 2007
hou et al. 2007#
  28/49
  19/29
114/120
116/190
  69/87
  15/18
182/187
  96/146
    6/8
218/242
Total (95% CI)                                       1 076                                6 849
Total events: 913(Treatment), 3 395 (Control)
Test for heterogentity: x2=34.67, df=9 (P<0.00001)
Test for overall effect: Z=7.68 (P<0.0001)
158/898
137/322
309/388
510/835
263/565
  70/445
237/314
683/1 413
  61/100
967/1 569
b
0.001 0.01     0.1      1        10     100    1 000
Favours treatment   Favours control
11.47
  9.51
  8.98
12.82
11.92
  6.03
  8.41
13.64
  4.24
12.97
    6.24 (3.46, 11.28)
    2.57 (1.16, 5.69)
    4.86 (2.06, 11.45)
    4.41 (2.81, 6.91)
    4.40 (2.55, 7.59)
  26.79 (7.56, 94.96)
  11.83 (4.69, 29.82)
    2.05 (1.44, 2.93)
   1.92 (0.37, 9.99)
    5.65 (3.67, 8.72)
  100.00               4.78 (3.21, 7.13)
Wei Wang et al./Asian Pacific Journal of Tropical Medicine (2012)15-2322
schistosome-endemic areas, the schistosome infection has 
been under control and infection intensities are usually 
low[30]. A search for a better immunodiagnostic test or 
novel molecular biological tools that can be applied in field 
situations in China is essential and should be given high 
priority. 
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